Pharmacy

Jan 8 2018

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #tris #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Jan 7 2018

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #companies #in #usa

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Dec 24 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #list #of #pharmaceutical #companies

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Dec 21 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #pharmaceutical #chemistry

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Dec 5 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #small #pharma #companies

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Nov 26 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #small #pharma #companies

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Nov 9 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #scolr #pharma

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Oct 1 2017

TU-Automotive Detroit #telematics #update, #connected #car, #telematics, #conference, #detroit, #automotive, #internet #of #things, #internet #of #everything, #m2m, #v2v, #v2i, #v2x, #its, #intelligent #transport #systems, #autonomous #vehicles, #automated #vehicles, #adas, #connected #lifestyle, #smart #mobility, #ivi, #hmi, #cyber #security, #alternative #fuels, #driverless #cars, #aftermarket

# The Home of the Connected Car Pivot from Metal to Mobility: Create customer-first products and services, e.g. dynamic leasing in-car payments. Engage consumers and diversify revenue streams to unlock the new auto business Test Track or Highway? From tech development (perception AI) to overcoming societal barriers (regulation trust), map the billions of miles required to validate autonomous cars. What s the risk/ reward ratio? Cybersecurity Never Sleeps: With connected car attack surfaces proliferating, collaborate with regulators, associations and partners to create best practices for end-to-end cybersecurity Next-Gen Wireless Infrastructure: Evaluate 5G vs. LTE vs. DSRC for the roll out …

Sep 9 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #india #pharma

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Aug 24 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #sk #pharma

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Aug 10 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #api #pharma

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Aug 7 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #it #jobs

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Jul 31 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharmaceutical #industry #today

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Jul 25 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #pharmaceutical #manufacturing #process

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Jul 23 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #draxis #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Jul 11 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #www.buy-pharma.com

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Jul 9 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #antares #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Jun 25 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #esai #pharma

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Jun 15 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #evaluate #pharma

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

May 30 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #top #ten #pharmaceutical #companies

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

May 15 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #biotech #company

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Apr 28 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #ferring #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Apr 26 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #pricing

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Apr 19 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #acceleron #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Apr 12 2017

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #bio #pharmaceutical #companies

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Apr 8 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #novartis #pharma

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Apr 1 2017

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #laureate #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Mar 29 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #penn #pharma

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Feb 11 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #times

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Dec 9 2016

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #sk #pharma

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Nov 21 2016

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #leo #pharma #canada

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Nov 14 2016

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #wuxi #pharma

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Nov 11 2016

Endo Pharma’s stock logs its largest one-day loss in 14 years #ajanta #pharma #kamagra

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Nov 7 2016

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #pharma #stocks

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Oct 29 2016

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #cerulean #pharma

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Oct 27 2016

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #isis #pharma #products

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Oct 23 2016

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) #pharmaceutical #industry #overview #2013

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Oct 5 2016

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo #top #pharmaceutical #company

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …

Sep 21 2016

How Novartis Pharma Business Split Will Impact its Business (NVS, GSK)

#novartis pharma # How Novartis Pharma Business Split Will Impact its Business (NVS, GSK) In the wake of another high-profile exit, Novartis ( NVS ) is undergoing an ambitious new strategy and restructuring its business divisions. (For more, see: Interested In Pharmaceutical Stocks? Try Novartis (ADR) . ) The Developments In a recent press release. the company announced two changes, which will be effective on July 1, 2016. First, David Epstein, who heads the American pharmaceuticals division for Novartis, will leave after a 27-year long tenure at the company. Second, the company is splitting its $49.4 billion pharmaceuticals division into …

Sep 18 2016

Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site – Liverpool Echo

#teva pharma jobs # Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site The Teva pharmaceuticals site on Aston Lane South in Runcorn. Picture: ROB STAFFORD The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities where possible. The firm is an Israeli-American multinational pharmaceutical company headquartered in Petah Tikva, Israel and has four main locations in the UK which include a distribution centre in West Yorkshire, offices …